Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Media
Case-Based Peer PerspectivesInvestigator Perspectives Medical World NewsPodcastsUrology Medical PerspectivesUTv VideosPeer ExchangeSpecial ReportVirtual Tumor BoardInsightsMedcastPeers & Perspectives
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Madison Krischak, MD

Advertisement

Articles by Madison Krischak, MD

Madison Krischak, MD, on using nephrometry scores to target renal biopsy

ByMadison Krischak, MD
December 18th 2025

Madison Krischak, MD, outlines key findings from a study looking at the use of nephrometry scores to guide routine renal mass biopsies.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Urology Times

    1

    FDA approves rucaparib for chemotherapy-naïve, BRCA-mutated mCRPC

    2

    FDA approves flibanserin for hypoactive sexual desire disorder in postmenopausal women

    3

    Perioperative EV plus pembrolizumab extends survival in cisplatin-eligible MIBC

    4

    John Michael DiBianco, MD, outlines rationale for the SOUL trial

    5

    Study finds microRNA-based assay may reduce costs, improve QALYs in prostate cancer

    • About Us
    • Advertise
    • Editorial
    • Contact Us
    • Job Board
    • Terms and Conditions
    • Privacy
    • Do not sell my Personnal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us